Showing results (1-10 of 1,196) with videos related to
Sort By:
Pageof 120
American Journal of Hematology|August 13, 2004
Cell proliferation of myeloma plasma cells: comparison of the blood and marrow compartmentsShaji Kumar, S Vincent Rajkumar, Philip R Greipp, et al.British Journal of Haematology|July 9, 2003
Bone marrow angiogenesis and circulating plasma cells in multiple myelomaShaji Kumar, Thomas E Witzig, Philip R Greipp, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Thalidomid: current role in the treatment of non-plasma cell malignanciesShaji Kumar, Thomas E Witzig, S Vincent RajkumarBlood|May 8, 2004
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progressionShaji Kumar, Thomas E Witzig, Michael Timm, et al.British Journal of Haematology|October 9, 2003
Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myelomaMichael A Thompson, Thomas E Witzig, Shaji Kumar, et al.British Journal of Haematology|March 6, 2008
Anti-CD20 monoclonal antibody therapy in multiple myelomaPrashant Kapoor, Patricia T Greipp, William G Morice, et al.British Journal of Haematology|November 20, 2002
Bone marrow angiogenesis in multiple myeloma: effect of therapyShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significanceShaji Kumar, S Vincent Rajkumar, Robert A Kyle, et al.Blood|October 24, 2002
Prognostic value of angiogenesis in solitary bone plasmacytomaShaji Kumar, Rafael Fonseca, Angela Dispenzieri, et al.Pageof 120